NASDAQ:FBIO
Fortress Biotech Stock News
$1.75
-0.0500 (-2.78%)
At Close: May 03, 2024
7 Penny Stocks That May Not Be Penny Stocks For Long
02:39pm, Wednesday, 21'st Apr 2021
Many penny stocks are destined for bankruptcy, but there are some that will survive. Wall Street thinks these companies are undervalued.
Why Fortress Biotech Stock Is Sinking Today
03:09pm, Tuesday, 13'th Apr 2021
Investors were not thrilled with the company's latest regulatory update.
Is the Options Market Predicting a Spike in Fortress Biotech (FBIO) Stock?
09:51am, Monday, 12'th Apr 2021
Investors need to pay close attention to Fortress Biotech (FBIO) stock based on the movements in the options market lately.
Fortress Biotech (FBIO) Surges 11.5%: Is This an Indication of Further Gains?
07:35am, Monday, 12'th Apr 2021
Fortress Biotech (FBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
FBIO Stock: Over 10% Increase Pre-Market Explanation
06:08am, Monday, 12'th Apr 2021
The stock price of Fortress Biotech (NASDAQ: FBIO) increased by over 10% pre-market. This is why it happened.
Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
08:30am, Wednesday, 07'th Apr 2021
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or mon
Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank
07:00am, Monday, 05'th Apr 2021
SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), tod
The first and only prescription cloth towelette approved to treat primary axillary hyperhidrosis in people nine-years of age and older is Journey Medical's seventh marketed dermatology product The fir
Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights
04:15pm, Wednesday, 31'st Mar 2021
Revenue from marketed dermatology products increased 28% for full-year 2020 compared to 2019
Will Fortress Biotech (FBIO) Report Negative Q4 Earnings? What You Should Know
01:38pm, Monday, 08'th Mar 2021
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FBIO Stock Price Increased 26.03%: Why It Happened
08:54am, Wednesday, 03'rd Mar 2021
The stock price of Fortress Biotech, Inc. (Nasdaq: FBIO) has increased by 26.03%. This is why it happened.
Caelum Biosciences Announces Collaborations with the Amyloidosis Advocacy Community and Support of Amyloidosis Awareness Month
08:00am, Monday, 01'st Mar 2021
BORDENTOWN, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases, today
Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
08:00am, Friday, 26'th Feb 2021
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on acquiring, developing and commercializing or mon
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
08:00am, Monday, 22'nd Feb 2021
Catherine Bowes Rickman, Ph.D., FARVO, a leading age-related macular degeneration researcher, appointed to Scientific Advisory Board
LOS ANGELES--(BUSINESS WIRE)---- $FBIO #FBIO--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc.
